Zenith Capital Corp
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company's lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration with Astellas and Newsoara, as well as advanced or meta… Read more
Zenith Capital Corp (ZHCLF) - Total Liabilities
Latest total liabilities as of July 2024: $29.97K USD
Based on the latest financial reports, Zenith Capital Corp (ZHCLF) has total liabilities worth $29.97K USD as of July 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zenith Capital Corp - Total Liabilities Trend (2013–2024)
This chart illustrates how Zenith Capital Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zenith Capital Corp Competitors by Total Liabilities
The table below lists competitors of Zenith Capital Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
T T Limited
NSE:TTL
|
India | ₹936.11 Million |
|
Nuvotec
KQ:060260
|
Korea | ₩32.17 Billion |
|
Induct AS
OL:INDCT
|
Norway | Nkr12.41 Million |
|
Macromill Embrain Co. Ltd
KQ:169330
|
Korea | ₩20.18 Billion |
|
Arrowhead Properties Ltd B
JSE:FTB
|
South Africa | ZAC4.72 Billion |
|
Rokiskio Suris AB
MU:YTV
|
Germany | €65.76 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Zenith Capital Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zenith Capital Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zenith Capital Corp (2013–2024)
The table below shows the annual total liabilities of Zenith Capital Corp from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-04-30 | $27.57K | +52.91% |
| 2023-04-30 | $18.03K | +236.13% |
| 2022-04-30 | $5.36K | -2.90% |
| 2021-04-30 | $5.52K | -19.71% |
| 2020-04-30 | $6.88K | -10.54% |
| 2019-04-30 | $7.69K | +353.21% |
| 2018-04-30 | $1.70K | -45.12% |
| 2017-04-30 | $3.09K | -72.35% |
| 2016-04-30 | $11.18K | +53.35% |
| 2015-04-30 | $7.29K | +1.89% |
| 2014-04-30 | $7.16K | -62.11% |
| 2013-04-30 | $18.89K | -- |